Expression of complement inhibitor protein CD59 in human neuronal and glial cell lines treated with HIV-1 gp41 peptides

Journal of NeuroVirology

Volumn 6, Issue 1, 2000, Pages 51-60

  Chong, Young Hae ^a   Lee, Myung Ju ^a  

^a Ewha Womans University   (South Korea)

Author keywords

Anti inflammatory agents; Antioxidants; CD59; Gp41; HIV 1 associated dementia; Proinflammatory cytokines; Protein kinase inhibitor

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; CD59 ANTIGEN; COMPLEMENT INHIBITOR; GAMMA INTERFERON; GLYCOPROTEIN GP 41; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MESSENGER RNA; PHORBOL DIBUTYRATE; PROTEIN KINASE C INHIBITOR; STAUROSPORINE; TUMOR NECROSIS FACTOR ALPHA; VIRUS PROTEIN;

ARTICLE; ASTROCYTE; CONTROLLED STUDY; DEMENTIA; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOBLOTTING; INFLAMMATION; NERVE CELL CULTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ALPHAVIRUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0034107257     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.3109/13550280009006382     Document Type: Article

References (48)

1. Adamson DC, Wildemann B, Sasak MI, Glass JD, Mcarthur JC, Christov VI, Dawson TM, Dawson VL (1996). Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV-1 gp41. Science 274: 1917-1921.
2. Aisen PS (1997). Inflammation and Alzheimer's disease: mechanisms and therapeutic strategies. Gerontol 43: 143-149.
3. Akatsu H, Yamada T, Okada N, Yamamoto T, Yamashina M, Okad HA (1997). Unique expression of HRF (CD59) in human nervous tissue. Microbiol Immunol 41: 321-329.
4. Aries SP, Schaaf B, Hansen F, Weyrich K, Kurowski V, Dennin R, Dalhoff K (1997). Expression of complement receptors and regulatory proteins on alveolar CD4+ lymphocytes from human immunodeficiency virus-1 infected individuals. Eur Resp J 10: 1736-1741.
5. Cadman ED, Puttfarcken PS (1997). β-amyloid peptides initiate the complement cascade without producing a comparable effect on the terminal pathway in vitro. Expt Neuronal 146: 388-394.
6. Chong YH (1997). Effect of a carboxy-terminal fragment of the Alzheimer amyloid precursor protein on expression of proinflammatory cytokines in rat glial cells. Life Sci 23: 2323-2333.
7. Chomczinsky P, Sacchi N (1987). Single step method of RNA isolation by acid guanidium thiocyanate-phenolchloroform extraction. Anal Biochem 162: 156-159.
8. Corasaniti MT, Melino G, Navarra M, Garaci E, FinazziAgro A, Nistico G (1995). Death of cultured neuroblastoma cells induced by HIV-1 gp120 is prevented by NMDA receptor antagonists and inhibitors of nitric oxide and cycloxygenase. Neurodegen 4: 315-321.
9. Denner J, Norley S, Kurth R (1994). The immunosuppressive peptide of HIV-1: functional domains and immune response in AIDS patients. AIDS 8: 1063-1072.
10. Fontana A, Fierz W, Wekerle H (1984). Astrocytes present myelin basic protein to encephalitogenic cell lines. Nature 307: 273-276.
11. Gasque P, Morgan BP (1996a). Complement regulatory protein expression by a human oligodendrocyte cell line: cytokine regulation and comparison with astrocytes. Immunol 89: 338-347.
12. Gasque P, Thomas A, Fontaine M, Morgan BP (1996b). Complement activation on human neuroblastoma cell lines in vitro: route of activation and expression of functional complement regulatory proteins. J Neuroimmunol 66: 29-40.
13. Glass JD, Johnson RT (1996). Human immunodeficiency virus and the brain. Annu Rev Neurosci 19: 1-26.
14. Haraguchi S, Good RA, Day NK (1995). Immunosuppressive retroviral peptides: cAMP and cytokine patterns. Immunol Today 16: 595-603.
15. Herzenberg LA, De Rosa SC, Dubs JG, Roederer M, Anderson MT, Ela SW, Herzenberg LA (1997). Glutathione deficiency is associated with impaired survival in HIV disease. Proc Natl Acad Sci USA 94: 1967-1972.
16. Holguin MH, Martin CB, Eggett T, Parker CJ (1996). Analysis of the gene that encodes the complement regulatory protein, membrane inhibitor of reactive lysis (CD59). Identification of an alternatively spliced exon and characterization of the transcriptional regulatory regions of the promoter. J Immunol 157: 1659-1668.
17. Itescu S (1996). Rheumatic aspects of acquired immunodeficiency syndrome. Cur Opin Rheumatol 8: 346-353.
18. Jones J, Morgan BP (1995). Apoptosis is associated with reduced expression of complement regulatory molecules, adhesion molecules and other receptors on polymorphonuclear leucocytes: functional relevance and role in inflammation. Immunol 86: 651-660.
19. Kalebic T, Masiero L, Onisto M, Garbisa S (1994). HIV-1 modulates the expression of golatinase A and B in monocyic cells. Biochem Biophy Res Comm 205: 1243-1249.
20. Koka P, He K, Zack JA, Kitchen S, Peacock W. Fried I, Tran T, Yashar SS, Merrill JE (1995). Human immunodeficiency virus 1 envelope proteins induce interleukin 1, tumor necrosis factor alpha, and nitric oxide in glial cultures derived from fetal, neonatal, and adult human brain. J Exp Med 182: 941-951.
21. Marchbank KJ, Morgan BP, Van Den Berg CW (1995). Regulation of CD59 expression on K562 cells: effects of phorbol myristate acetate, cross-linking antibody and non-lethal complement attack. Immunol 85: 146-152.
22. Marschang P, Kruger U, Ochsenbauer C, Gurtler L, Hittmair A, Bosch V, Patsch JR, Dierich MP (1997). Complement activation by HIV-1 infected cells: the role of transmembrane glycoprotein gp41. J. Acq. Immun. Deficiency Syndrome. J Acquired Immune Defic Syndr Hum Retrovirol 14: 102-109.
23. Masliah E, Achim CL, Ge N, Eeteresa RD, Terry RD, Wiley CA (1992). Spectrum of human immunodeficiency virus-associated neocortical damage. Ann Neurol 32: 321-329.
24. McGeer PI, McGeer EG (1995). The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res Rev 21: 195-218.
25. Meri S, Morgan BP, Davies A, Danials RH, Olavesen MG, Waldmaann H, Lachmaann PJ (1990). Human protein (CD59), an 18,000-20,000 MW complement lysis restriction factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers. Immunol 71: 1-9.
26. Mizuguchi M, Ikeda K, Namba Y, Kim SU (1992). Alzheimer's disease β-amyloid precursor protein in rat neural cells in culture. Gerontol 38: 15-23.
27. Montefiori DC, Cornell RJ, Zhou ZY, Zhou ZT, Hirsch VM, Johnson PR (1994). Complement control proteins, CD46, CD55, and CD59, as common surface constituents of human and siminan viruses and possible targets for vaccine protection. Virol 205: 82-92.
28. Morgan BP (1994). Clinical complementology: Recent progress and future trends. Eur J Clinic Invest 24: 219-228.
29. Morgan BP, Gasque P, Singhrao S, Piddlesden SJ (1997). The role of complement in disorders of the nervous system. Immunopharmacol 38: 43-50.
30. ++: relationship to human immunodeficiency virus (HIV)-induced cellularhyporesponsiveness. Proc Soc Exp Biol Med 207: 284-291.
31. Nottet HS, Jett M, Flanagan CR, Zhai QH, Persidky Y, Rizzimo A, Berton EW, Gents P, Baldwin T, Schwartz J, Labenz CJ, Gendelman HE (1995). A regulatory role for astrocytes in HIV-1 encephalitis: An overexpression of eicosanoids, platelet-activating factor, and tumor necrosis factor-by activated HIV-1-infected monocytes is attenuated by primary human astrocytes. J Immunol 154: 3567-3581.
32. Ogino Y, Costa T (1992). The epithelial phenotype of human neuroblastoma cells express bradykinin. J. Neurochem. J Neurochem 58: 46-56.
33. Ponte P, Ng S-Y, Gunning P, Kedes L (1984). Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human beta-actin cDNA. Nucleic Acids Res 12: 1687-1696.
34. Ratner L, Haseltine W, Partarca R, Livak KJ, Statcich B, Josephs SF, Doran ER, Rafaski JA, Whitehorn EA, Baumeister K, Ivanoff L, Peytteway SR JR, Pearson JA, Lautenberger ML, Papas TS, Ghrayeb J, Chang NT, Gallo R, Wong-Staal CF (1985). Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature 313: 277-284.
35. Rogers CA, Gasque P, Piddlesden SJ, Okada N, Holers VM, Morgan BP (1996). Expression and function of membrane regulators of complement on rat astrocytes in culture. Immunol 88: 153-161.
36. Rogers J, Cooper N, Webster S, Schultz J, McGeer P, Styren SD, Civin WH, Brachova L, Bradt B, Ward P, Lieberburg I (1992). Complement activation by β-amyloid in Alzheimer's disease. Proc Natl Acad Sci USA 89: 10016-10020.
37. Ruegg CL, Strand MA (1991). Synthetic peptide with sequence identity to the transmembrane protein Gp41 of HIV-1 inhibits distinct lymphocytes activation pathways dependent on protein kinase C and intra-cellular calcium influx. Cell Immunol 137: 1-13.
38. Saifuddin M, Hedayati T, Atkinson JP, Holguin MH, Parker CJ, Spear GT (1997). Human immunodeficiency virus type 1 incorporates both glycosyl phosphatidy-linositol-anchored CD55 and CD59 and integral membrane CD46 at levels that protect from complement-mediated destruction. J Gen Virol 78: 1907-1911.
39. Sawada R, Ohashi K, Anaguchi H, Okazaki H, Hattori M, Minao N, Naruto M (1992). Isolation and expression of the full-length cDNA encoding CD59 antigen of human lymphocytes. DNA Cell Biol 9: 213-220.
40. Schmitz J, Zimmer JP, Kluxen B, Aries S, Bogel M, Gigli I, Schmitz H (1995). Antibody-dependent complement mediated cytotoxicity in sera from patients with HIV-1 infection is controlled by CD55 and CD59. J Clin Invest 96: 1520-1526.
41. Shen Y, Sullivan T, Lee C-M, Meri S, Shiosaki K, Lin CW (1998). Induced expression of neuronal membrane attack complex and cell death by Alzheimer's β-amyloid peptide. Brain Res 796: 187-197.
42. Spiller OB, Moretto G, Ki SU, Morgan BP, Devine DV (1996). Complement expression on astrocytes and astrocytoma cell lines: failure of complement regulation at the C3 level correlates with very low CD55 expression. J Neuroimmunol 71: 97-106.
43. Stoiber H, Clivio A, Dierich MP (1997). Role of complement in HIV infection. Annu Rev Immunol 15: 649-674.
44. Thielens NM, Bally IM, Ebenbichler CF, Dierich MP (1993). Further characterization of the interaction between the C1q subcomponent of human C1 and the transmembrane envelope glycoprotein gp41 of HIV-1. J Immunol 151: 6583-6592.
45. Toggas SM, Masliah E, Rockenstein EM, Mucke L (1994). Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature 367: 188-193.
46. Tsuji S, Kaji K, Nagasawa S (1994). Activation of the alternative pathway of human complement by apoptotic human umbilical vein endothelial cells. J Biochem 116: 794-800.
47. Weiss L, Okada N, Haeffner Cavaillon N, Hattori T, Faucher C, Kazatchkine MD, Okada H (1992). Decreased expression of the membrane inhibitor of complement-mediated cytolysis CD59 on T-lymphocytes of HIV-infected patients. AIDS 6: 379-385.
48. Yeung MC, Pulliam L, Lau AS (1995). The HIV envelope protein gp120 is toxic to human brain-cell cultures through the induction of interleukin-6 and tumor necrosis factor. AIDS 9: 137-143.